Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG known ✓ | P37231 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 4/20 | 0.41 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 3/20 | 0.39 |
| ▸ | RXRG | P48443 | 2/20 | 0.39 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29785771 | 1.00 | ATM (0.52) | ATMPPARGALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL2743027 | 0.84 | ATM (0.51) | ATMPPARGALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL3102000 | 0.83 | ATM (0.50) | ATMPPARGALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL10299029 | 0.81 | ATM (0.51) | ATMPPARGALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL1965566 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2MAPTRAB9AHPGD | |
| SCHEMBL6659601 | 0.75 | ATM (0.61) | ATMALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL10448372 | 0.74 | CA12 (0.48) | ALDH1A1HTTSMN1; SMN2L3MBTL1GAA | |
| SCHEMBL1964224 | 0.73 | DUSP5 (0.50) | MAPTDUSP5 | |
| SCHEMBL6664749 | 0.71 | LMNA (0.63) | ATMPPARGALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL9557135 | 0.71 | CA2 (0.59) | ATMALDH1A1L3MBTL1SRD5A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3039087-B1 | CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS | HERAEUS MEDICAL COMPONENTS LLC (US) | 2023-12-06 | — | — | EP | claimed |
| US-10800931-B2 | Conductive polymeric coatings, medical devices, coating solutions and methods | HERAEUS MEDICAL COMPONENTS LLC (US) | 2020-10-13 | — | — | US | claimed |
| US-20170304506-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | BANK OF MONTREAL, AS COLLATERAL AGENT | 2017-10-26 | — | — | US | claimed |
| US-20160208114-A1 | CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS | HERAEUS MEDICAL COMPONENTS LLC | 2016-07-21 | — | — | US | claimed |
| EP-3039087-A1 | CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS | SurModics, Inc. (US) | 2016-07-06 | — | — | EP | claimed |
| US-9375517-B2 | Lubricious medical device coating with low particulates | SURMODIES, INC. (US) | 2016-06-28 | — | — | US | claimed |
| EP-2804915-B1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS INC (US) | 2016-03-30 | — | — | EP | claimed |
| WO-2015031265-A1 | CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS | SURMODICS, INC. (US) | 2015-03-05 | — | — | WO | claimed |
| EP-2804915-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SurModics, Inc. (US) | 2014-11-26 | — | — | EP | claimed |
| US-20130197433-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS, INC. (US) | 2013-08-01 | — | — | US | claimed |
| WO-2013109930-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS, INC. (US) | 2013-07-25 | — | — | WO | claimed |
| US-20260108662-A1 | LUBRICIOUS COATING FOR MEDICAL DEVICE | SURMODICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108663-A1 | LOW PARTICULATE LUBRICIOUS COATING WITH VINYL PYRROLIDONE AND ACIDIC POLYMER-CONTAINING LAYERS | SURMODICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | SURMODICS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12472288-B2 | Lubricious coating for medical device | SURMODICS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20130197433-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| WO-2013109930-A1 | LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES | SURMODICS, INC. (US) | 2013-07-25 | — | — | WO | disclosed |
| EP-2424581-A2 | DEVICES AND METHODS FOR DELIVERY OF BIOACTIVE AGENTS | SurModics, Inc. (US) | 2012-03-07 | — | — | EP | disclosed |
| WO-2010129328-A2 | DEVICES AND METHODS FOR DELIVERY OF BIOACTIVE AGENTS | SURMODICS, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20100272774-A1 | DEVICES AND METHODS FOR DELIVERY OF BIOACTIVE AGENTS | SURMODICS, INC. (US) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108662-A1 | LUBRICIOUS COATING FOR MEDICAL DEVICE | MUC1, ADH1A, PTK2 | PPARG 3692/4885ATM 117/4885ALDH1A1 45/4885 |
| US-20260098225-A1 | POLYACRYLIC ACID CONTAINING LUBRICIOUS COATINGS FOR MEDICAL DEVICES WITH ENHANCED PROPERTIES | CUTA, EED, SELP | PPARG 2746/4885ATM 1064/4885ALDH1A1 135/4885 |
| US-20260108663-A1 | LOW PARTICULATE LUBRICIOUS COATING WITH VINYL PYRROLIDONE AND ACIDIC POLYMER-CONTAINING LAYERS | VCL, RAD54L, SELP | PPARG 2702/4885ATM 67/4885ALDH1A1 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.